证券代码：002360 证券简称：同德化工 公告编号：2023-055 1、基本情况 山西同德化工股份有限公司（以下简称"同德化工"或"公司"）为进一步 加强控股子公司广灵县同德精华化工有限公司（以下简称"广灵同德"）的控制 与管理，提高决策效率，整合相关资源。目前，公司已与深圳前海南方国能资产 管理有限公司共同签署了《股权转让协议》:公司拟以人民币2,300万元受让深圳 前海南方国能资产管理有限公司持有的广灵同德20%股权，在本次股权受让完成 后，广灵同德成为公司的全资子公司。 2、投资履行的审批程序 根据《公司章程》及有关规范性文件规定，本投资事项已经公司董事长审批 通过,在公司董事长权限范围内，无需提交公司董事会和股东大会进行审议。 山西同德化工股份有限公司 关于收购控股子公司广灵县同德精华化工有限公司 少数股东股权的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、交易概述 3、根据有关法律、法规及其他有关规定，本次对外投资不构成关联交易， 也不构成《上市公司重大资产重组管理办法》规定的重大资产重组。 二、交易对方的基本情况 1、公司名称：深圳 ...

Financial Performance - The company's operating revenue for Q3 2023 was CNY 249,164,919.20, a decrease of 29.48% compared to the same period last year[5] - The net profit attributable to shareholders for Q3 2023 was CNY 61,520,591.42, an increase of 6.25% year-on-year[5] - The company's operating profit for Q3 2023 was CNY 188,059,330.32, a decrease of 5.4% from CNY 197,952,430.11 in Q3 2022[20] - The total revenue from operating activities was CNY 733,168,980.62, down 18.9% from CNY 904,115,345.07 in the same quarter last year[22] - The total operating costs decreased to CNY 562,980,703.44 from CNY 628,490,034.28, representing a reduction of about 10.4%[19] - The company reported a total comprehensive income of CNY 152,182,932.48, compared to CNY 144,351,347.65 in the previous year, reflecting a growth of 5.7%[21] - Basic earnings per share for Q3 2023 were CNY 0.37, slightly up from CNY 0.36 in the same period last year[21] Assets and Liabilities - The total assets at the end of Q3 2023 reached CNY 4,006,385,781.97, representing a growth of 33.48% compared to the end of the previous year[5] - The company's total liabilities amounted to CNY 2,099,927,378.12, up from CNY 1,249,708,259.23 at the start of the year, indicating a significant increase in leverage[17] - The total current assets increased to CNY 1,230,622,833.41 from CNY 867,134,892.35, reflecting a growth of approximately 41.9%[16] - Long-term borrowings increased to CNY 698,000,000.00 from CNY 248,000,000.00, indicating a strategic move to finance growth initiatives[17] - The total liabilities increased significantly, with borrowings reaching CNY 1,232,749,999.93, compared to CNY 575,000,000.00 in the previous year[23] Cash Flow - The cash flow from operating activities showed a net outflow of CNY 222,233,902.08, a decrease of 22.81% year-on-year[5] - The net cash flow from operating activities was CNY 222,233,902.08, a decrease of 22.8% compared to CNY 287,917,182.58 in Q3 2022[23] - The company recorded a net cash inflow from financing activities of CNY 757,824,900, an increase of 82.25% compared to the previous period[9] - The company experienced a net cash outflow from investing activities of CNY 648,188,071.50, compared to a net outflow of CNY 722,405,605.91 in the same period last year[23] - The cash and cash equivalents at the end of the period were CNY 649,133,984.54, an increase from CNY 399,756,854.34 at the end of the previous year[23] - The company reported a significant increase in cash and cash equivalents, with a year-end balance of CNY 649,134,000, up 104.62% from the beginning of the period[9] Shareholder Information - The total equity attributable to shareholders rose to CNY 1,818,952,742.73, a 9.15% increase from the end of the previous year[5] - The company's equity attributable to shareholders increased to CNY 1,818,952,742.73 from CNY 1,666,414,408.61, reflecting a growth of approximately 9.2%[17] - The number of ordinary shareholders at the end of the reporting period was 17,029[11] Future Plans and Investments - The company is constructing a new production line for 60,000 tons of biodegradable plastics (PBAT) and 240,000 tons of 1,4-butanediol (BDO), which is a significant investment in sustainable materials[13] - The company plans to complete the issuance of new shares within 12 months following the approval from the China Securities Regulatory Commission[13] Report Details - The third quarter report of Shanxi Tongde Chemical Co., Ltd. is unaudited[25] - The report was released on October 27, 2023[25] - No specific financial performance metrics or user data were provided in the report[25] - Future outlook and performance guidance were not detailed in the report[25] - Information regarding new products or technology development was not mentioned[25] - Market expansion and acquisition strategies were not discussed in the report[25] - Other new strategies were not outlined in the report[25] - The report does not include any numerical data or percentage changes[25] - The company did not provide any insights into operational performance[25] - The report lacks comprehensive financial analysis or key performance indicators[25]

证券代码：002360 证券简称：同德化工 公告编号：2023-053 山西同德化工股份有限公司 关于公司股东部分股权质押延期购回的公告 1、本次股份质押延期情况 | | 是否 | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 为控 | | | | | | | | | | | | 股东 | 股股 | 质押 | 占其 | 占公 | 是 | 是 | 质押起始日 | 原质押到期 | 延期后质 | 质权人 | 质押 | | 名称 | 东或 | 数量 | 所持 | 司总 | 否 | 否 | | 日 | 押到期日 | | 用途 | | | 第一 | （万 | 股份 | 股本 | 为 | 为 | | | | | | | | | 股） | | | | | | | | | | | | 大股 | | 比例 | 比例 | 限 | 补 | | | | | | | | 东及 | | （%） | （%） | 售 | 充 | | | | | | | | 一致 | | | | 股 | 质 | ...

特此公告。 山西同德化工股份有限公司董事会 2023 年 9 月 4 日 证券代码：002360 证券简称：同德化工 公告编号：2023-052 关于控股子公司低浓度瓦斯发电项目建成投产的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 由山西同德化工股份有限公司（以下简称"公司"或"同德化工"）的全资子公 司余热宝科技有限公司，投资控股阳城县国泰中科清洁能源技术有限公司新建伏 岩煤矿乏风发电项目（15 兆瓦低浓度瓦斯发电项目），经过前期调试、试运行， 已于近日正式并网发电。 本项目符合国家"十四五"时期支持发展战略新兴产业，也是在"双碳"政 策背景下，国家鼓励发展的新型绿色能源产业项目；此项目通过引进集成国外先 进的废气氧化处理技术和设备，利用热电联产技术，回收利用煤矿低浓度抽放瓦 斯及超低浓度风排瓦斯，变废为宝，实现煤矿瓦斯零排放，解决伏岩煤业瓦斯供 热发电的清洁环保项目；项目的建成将对有效防范煤矿瓦斯事故，增加清洁能源 供应，减少温室气体排放，产生显著的安全效益、环境效益和资源综合利用的经 济效益，对销毁煤矿瓦斯具有引领带动示范效应；同时也有利于公司 ...

证券代码：002360 证券简称：同德化工 公告编号：2023-051 关于公司为控股孙公司提供担保的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、担保情况概述 为保证满足山西同德化工股份有限公司（以下简称"公司"或"同德化工"） 的全资子公司山西同德资产管理有限责任公司，控股的深圳市同德通供应链管理有 限公司（以下简称"同德通"）流动资金需求，公司第七届董事会第二十七次会议 及公司 2022 年度股东大会审议通过了《关于公司为全资及控股子公司提供担保的议 案》：同意公司为全资及控股子公司提供银行贷款担保总额合计不超过 30 亿元（具 体以实际担保额度为准）。 二、被担保人基本情况 1、控股孙公司名称：深圳市同德通供应链管理有限公司 统一社会信用代码：91440300MA5FLT337P 住册地址：深圳市前海深港合作区前湾一路 1 号 A 栋 201 室(入驻深圳市前海商 务秘书有限公司) 法定代表人：张烘 注册资本：人民币 1000 万元 成立日期：2019 年 5 月 14 日 经营范围：一般经营项目是：供应链管理及相关配套服务；电子产品、 ...

证券代码：002360 证券简称：同德化工 公告编号：2023-050 关于全资子公司取得银行授信额度的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 敬请广大投资者关注后续进展，注意投资风险。 山西同德化工股份有限公司（以下简称"公司"或"同德化工"）第七届董 事会第二十七次会议及公司 2022 年度股东大会审议通过了《关于公司及控股子 公司向银行申请贷款授信额度的议案》。基于全资子公司同德科创材料有限公司 （以下简称"同德科创"）投资新建年产 6 万吨生物降解塑料（PBAT）及其原料 年产 24 万吨 1，4 丁二醇(BDO)一体化生产线项目，是国家"十四五"时期支持 发展战略新兴产业，也是山西省太忻经济一体化经济区重点工程项目。截至目前， 同德科创实施本项目向银行申请贷款授信的进展公告如下： 全资子公司同德科创已取得向中国建设银行股份有限公司山西省分行 3 亿 元固定资产项目贷款批复，期限为 7 年，其他银行也正在授信审批中。此项目贷 款最终贷款金额、期限、还款方式等条款内容以全资子公司项目建设的实际需求 和借款合同具体内容为准。 本项目的建设符合 ...

Financial Performance - The company's operating revenue for the first half of 2023 was CNY 482,775,907.50, representing a 5.24% increase compared to CNY 458,755,288.81 in the same period last year[23]. - Net profit attributable to shareholders was CNY 88,602,623.56, up 3.10% from CNY 85,940,521.70 year-on-year[23]. - The net cash flow from operating activities reached CNY 180,892,723.41, an increase of 3.82% compared to CNY 174,229,739.80 in the previous year[23]. - Total assets at the end of the reporting period were CNY 3,291,008,627.42, reflecting a 9.65% increase from CNY 3,001,505,600.79 at the end of the previous year[23]. - The company's basic earnings per share rose to CNY 0.22, a 4.76% increase from CNY 0.21 in the same period last year[23]. - The diluted earnings per share increased by 10.00% to CNY 0.22 from CNY 0.20 year-on-year[23]. - The company reported a total profit of 4.451 billion yuan for the first half of 2023, representing a year-on-year increase of 35.74%[36]. - The total tax and profit generated by the blasting industry reached 6.087 billion yuan, up 24.99% year-on-year[36]. - The total revenue for the first half of 2023 was 940.87 million yuan, representing a decrease of 2.0% compared to the previous period[155]. - The net profit attributable to shareholders was 478.75 million yuan, down 1.8% year-on-year[156]. Investment and Capital Expenditure - The company is constructing a new integrated production line for 60,000 tons of biodegradable plastic (PBAT) and 240,000 tons of 1,4-butanediol (BDO), expected to commence trial production by the end of 2023[31]. - The company reported a total investment of 1,529 million CNY in the PBAT project, with a cumulative input of 145.2 million CNY and a funding progress of 73.53%[58]. - The company invested ¥149,022,071.91 during the reporting period, a significant decrease of 92.85% compared to ¥404,000,000 in the same period last year[56]. - The company has allocated 147.5 million yuan for research and development in the current fiscal year, a 15% increase from the previous year[161]. Cash Flow and Liquidity - The cash and cash equivalents net increase was CNY 82,678,981.59, a substantial improvement compared to -CNY 3,302,706.66 in the previous year[42]. - The company's cash and cash equivalents increased to ¥399,921,534, representing 12.15% of total assets, up from 10.57% at the end of the previous year, a change of 1.58%[49]. - The ending balance of cash and cash equivalents was CNY 399,921,534.99, slightly down from CNY 415,164,878.42 at the end of the previous year[147]. - Cash inflow from financing activities totaled CNY 454,700,789.91, an increase of 13.1% compared to CNY 401,733,504.08 in the previous year[147]. - Net cash flow from financing activities decreased to CNY 98,856,985.97, down 60% from CNY 247,130,646.04 year-on-year[147]. Risks and Challenges - The company faces various risks including macroeconomic and policy risks, raw material price fluctuations, and intensified market competition[3]. - The company is exposed to raw material price volatility, particularly ammonium nitrate, which significantly impacts profit margins[68]. - The company is at risk of reduced market demand due to economic transitions and industry restructuring, which may affect operational performance[72]. - The company faces risks from macroeconomic conditions, including slowing domestic demand and increased competition in the civil explosives market[66]. Corporate Governance and Shareholder Information - The company held its first extraordinary shareholders' meeting on March 14, 2023, with an investor participation rate of 28.03%[75]. - The annual shareholders' meeting took place on May 16, 2023, with a participation rate of 30.45%[75]. - The total number of ordinary shareholders at the end of the reporting period is 16,749[116]. - The largest shareholder, Zhang Yunsheng, holds 19.93% of the shares, totaling 80,057,500 shares, with 39,800,000 shares pledged[116]. Safety and Compliance - The company has maintained a zero-accident record in production and operations for over 30 years, highlighting its commitment to safety[38]. - The company did not face any significant environmental penalties during the reporting period and adheres to national environmental laws and regulations[81]. - Safety management is a priority, with the company implementing strict safety protocols and investing in employee training to mitigate risks[67]. Market and Product Development - The company’s biodegradable plastic project aligns with national policies promoting new technologies and materials, aiming to address environmental concerns and market demand[32]. - The company has initiated new product development projects aimed at expanding its market share in the chemical industry[153]. - The company plans to enhance its market expansion strategy by exploring new geographical regions and increasing its distribution network[153]. - The company is focusing on technological advancements to improve production efficiency and reduce costs[153]. Financial Reporting and Compliance - The half-year financial report has not been audited[88]. - The financial statements were prepared in accordance with the accounting standards issued by the Ministry of Finance, ensuring compliance and transparency[176]. - The company confirmed that its financial reports accurately reflect its financial position as of June 30, 2023, and its operational results for the first half of 2023[179].

证券代码：002360 证券简称：同德化工 公告编号：2023-034 关于参加山西辖区上市公司2023年投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，山西同德化工股份有限公司（以下简 称 "公司"）将参加由中国证券监督管理委员会山西监管局、山西省上市公司协会 与深圳市全景网络有限公司联合举办的"2023 年山西辖区上市公司投资者集体 接待日活动"，现将有关事项公告如下： 1、活动时间：2023年5月11日（星期四）下午15:00-17:00 2、召开方式：本次活动将采用网络远程的方式举行，投资者可登录"全景路 演"网站（http://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演APP, 参与本次互动交流。 出席本次集体接待日的公司人员有：总经理、董事会秘书邬庆文先生，财务 总监金富春先生。 欢迎广大投资者积极参与！ 特此公告。 山西同德化工股份有限公司 董事会 2023年5月8日 ...

Revenue and Profit - The company's revenue for Q1 2023 was ¥178,181,357.03, representing a 0.98% increase compared to ¥176,460,166.04 in the same period last year[5]. - Net profit attributable to shareholders increased by 26.16% to ¥26,200,020.77 from ¥20,768,036.98 year-on-year[5]. - The net profit for Q1 2023 was CNY 26,967,530.94, an increase of 28.5% compared to CNY 21,055,813.65 in Q1 2022[18]. - The total comprehensive income for the quarter was CNY 26,967,530.94, up from CNY 21,055,813.65, reflecting a growth of 28.5%[18]. - The operating profit for the quarter was CNY 32,523,397.31, slightly up from CNY 32,250,776.39 in the same period last year[18]. - The total revenue from sales of goods and services was CNY 213,424,892.28, down from CNY 266,859,837.30 in the same quarter last year[19]. Earnings Per Share - The basic earnings per share increased by 40.00% to ¥0.07 from ¥0.05 in the same period last year[5]. - The diluted earnings per share rose by 75.00% to ¥0.07 compared to ¥0.04 in the previous year[5]. - Basic earnings per share increased to CNY 0.07 from CNY 0.05, representing a 40% growth year-over-year[19]. Cash Flow - The net cash flow from operating activities rose by 50.60% to ¥81,269,322.47, up from ¥53,963,803.57 in the previous year[5]. - Cash flow from operating activities generated a net amount of CNY 81,269,322.47, compared to CNY 53,963,803.57 in the previous year, marking a 50.5% increase[19]. - The company reported a net cash outflow from investing activities of CNY -107,441,702.06, compared to CNY -178,635,733.07 in the previous year[20]. - The net cash flow from financing activities was CNY -22,125,866.66, a decrease from CNY 26,837,165.30 in Q1 2022[20]. Assets and Liabilities - Total assets at the end of the reporting period were ¥3,075,299,908.89, a 2.46% increase from ¥3,001,505,600.79 at the end of the previous year[5]. - Current liabilities totaled ¥974,072,980.92, an increase from ¥928,383,132.13, reflecting a growth of approximately 4.9%[15]. - The company's total equity attributable to shareholders increased by 1.62% to ¥1,693,383,701.79 from ¥1,666,414,408.61 at the end of the previous year[5]. - The total equity attributable to shareholders reached ¥1,693,383,701.79, compared to ¥1,666,414,408.61 at the start of the year, showing an increase of about 1.6%[15]. Research and Development - R&D expenses for the period amounted to ¥4,320,600, reflecting a 62.19% increase compared to the previous period[8]. - Research and development expenses rose significantly to ¥4,320,611.37, compared to ¥2,663,889.24 in the previous period, indicating an increase of approximately 62.0%[17]. Other Financial Metrics - The company reported a significant decrease of 62.79% in the balance of receivables financing, attributed to an increase in payment settlements during the reporting period[8]. - The company experienced a 396.71% increase in other current liabilities, primarily due to an increase in advance payments received[8]. - The company's cash and cash equivalents decreased to ¥268,939,124.03 from ¥317,242,553.40, a decline of approximately 15.2%[13]. - Inventory levels increased to ¥57,699,208.58 from ¥55,122,953.15, representing a growth of about 4.7%[13]. - The long-term equity investments slightly increased to ¥125,588,060.79 from ¥125,426,641.87, indicating a marginal growth of approximately 0.1%[13]. - The company reported a net investment loss of ¥151,913.50, a significant improvement compared to a loss of ¥10,260,642.33 in the previous period[17]. - The company incurred income tax expenses of CNY 6,398,751.15, a decrease from CNY 11,821,139.63 in Q1 2022[18].

Financial Performance - The company's operating revenue for 2022 was CNY 1,090,095,464.82, representing a 27.86% increase compared to CNY 852,561,476.85 in 2021[21]. - The net profit attributable to shareholders for 2022 was CNY 183,977,760.35, a 53.14% increase from CNY 120,139,808.66 in 2021[21]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 185,685,843.18, up 69.58% from CNY 109,498,895.22 in 2021[21]. - The net cash flow from operating activities reached CNY 321,527,480.13, a significant increase of 186.18% compared to CNY 112,350,688.55 in 2021[21]. - The basic earnings per share for 2022 was CNY 0.46, reflecting a 53.33% increase from CNY 0.30 in 2021[21]. - Total assets at the end of 2022 amounted to CNY 3,001,505,600.79, a 40.84% increase from CNY 2,131,086,810.53 at the end of 2021[21]. - The net assets attributable to shareholders at the end of 2022 were CNY 1,666,414,408.61, up 19.25% from CNY 1,397,417,430.91 at the end of 2021[21]. Business Operations - The company has not changed its main business since its listing, and there have been no changes in controlling shareholders[20]. - The company reported quarterly revenues of CNY 176,460,166.04, CNY 282,295,122.77, CNY 353,347,742.61, and CNY 277,992,433.40 for Q1, Q2, Q3, and Q4 respectively in 2022[25]. - The company achieved a total revenue of 43.744 billion yuan, representing a year-on-year growth of 12.92%, and a total profit of 5.881 billion yuan, up 9.19% year-on-year[34]. - The production and sales of industrial explosives reached 4.3906 million tons and 4.3797 million tons respectively, showing a year-on-year decline of 0.55% and 0.83%[34]. - The production of on-site mixed explosives reached 1.4804 million tons, marking a year-on-year increase of 9.18%[34]. Strategic Initiatives - The company plans to increase the proportion of on-site mixed explosives to over 35% by the end of 2025, with a minimum licensed capacity of 12,000 tons/year for packaged industrial explosives production lines[38]. - The company aims to enhance its innovation capabilities, with R&D expenditure expected to reach 3.5% of operating income by leading enterprises[38]. - The company is focusing on digital transformation and the integration of smart manufacturing, with plans to improve data collection capabilities across key operational areas[39]. - The company is committed to enhancing safety standards and achieving a 100% compliance rate for safety production standardization at the enterprise level[38]. - The company is expanding its market presence in the biodegradable plastic sector, driven by increasing public awareness of environmental issues and government regulations[43]. Market and Industry Trends - The demand for civil explosives is projected to grow due to ongoing investments in infrastructure and mining sectors, despite potential short-term pressures[40]. - The civil explosives industry is expected to benefit from the government's continued investment in coal, non-coal mining, and urbanization projects, providing a favorable environment for growth[40]. - The top 10 companies in the industry are expected to account for over 60% of the total output value, indicating a trend towards increased industry concentration[38]. - The company faces various risks including macroeconomic and policy risks, safety risks, raw material price fluctuations, and intensified market competition[3]. Safety and Compliance - The company is actively pursuing safety production measures and has maintained a record of zero accidents over 30 years of operation[45]. - The company emphasizes safety management in the explosives industry, implementing strict safety regulations and investing in safety training and technology to enhance safety levels[109]. - Safety production is emphasized as a fundamental requirement for high-quality development, with a focus on implementing safety responsibility at all levels[107]. Research and Development - The company has been recognized as a high-tech enterprise by the Shanxi Provincial Science and Technology Department, indicating a focus on innovation and R&D[49]. - R&D investment amounted to ¥28,606,714.36 in 2022, a decrease of 3.66% from ¥29,693,401.69 in 2021, representing 2.62% of operating revenue, down from 3.48%[71]. - The number of R&D personnel decreased by 51.81% to 120 in 2022 from 249 in 2021, with the proportion of R&D personnel dropping to 5.99% from 22.69%[71]. Financial Management - The company reported a significant increase in revenue from other civil explosive materials, which surged by 114.56% to ¥59,362,440.19[52]. - Financial expenses surged by 159.10% to ¥28,675,624.39 due to increased loans and interest payments[68]. - The company has implemented a comprehensive profit distribution policy that aligns with shareholder interests and external financing conditions, ensuring transparency and fairness[153]. Governance and Shareholder Relations - The company maintains a robust governance structure, ensuring compliance with legal regulations and promoting transparency in operations and decision-making[120]. - The company has established a comprehensive performance evaluation system for its directors and senior management, ensuring transparency and fairness in assessments[121]. - The company will continue to enhance investor relations management to better convey its value and promote the growth of intrinsic and market value[104]. Environmental Responsibility - The company has implemented measures to enhance environmental protection and has achieved compliance with all pollutant discharge standards[164]. - The company has focused on developing environmentally friendly technologies and cost-reduction methods to create new profit growth points[71]. Future Outlook - The company plans to focus on the development of biodegradable plastics as part of its strategy to enhance its core competitiveness and ensure its leading position in the industry[102]. - In 2023, the company aims to strengthen its governance capabilities and improve risk prevention mechanisms to ensure sustainable development[103].